As shown in Figure 1C, CCK-8 array revealed that either HBx or URG11 overexpression increased cell viability of HCC, while CP administration dose-dependently suppressed the growth of both HepG2-HBx and HepG2-URG11 cells. This evidence concerns the gene CP and hepatocellular carcinoma.